News

Studies have shown that using statin drugs used to treat hyperlipidemia as a combination therapy can reduce the risk of ...
Ovarian cancer is a serious disease, but a number of new and better drugs have become available for the treatment of this cancer over the past few years. In addition, we have new and more effective ...
Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.
Study reveals how a new IgE antibody therapy reactivates immune cells, offering a promising approach to fighting ovarian ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
A group of scientists at Virginia Commonwealth University (VCU) may have the key to discovering cancers origins within the body as well as insights into new treatment strategies for Ovarian cancer.
Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can ...
Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.